118 related articles for article (PubMed ID: 4007764)
21. Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor.
Buchanan N; Eyberg C; Davis MD
Am J Clin Nutr; 1979 Dec; 32(12):2439-42. PubMed ID: 506967
[TBL] [Abstract][Full Text] [Related]
22. Induction of drug metabolizing enzymes by sulfinpyrazone.
Walter E; Staiger C; de Vries J; Zimmermann R; Weber E
Eur J Clin Pharmacol; 1981; 19(5):353-8. PubMed ID: 6113147
[TBL] [Abstract][Full Text] [Related]
23. Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man.
Ohnhaus EE; Breckenridge AM; Park BK
Eur J Clin Pharmacol; 1989; 36(1):39-46. PubMed ID: 2917586
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive assessment of microsomal enzyme activity in occupational medicine: present state of knowledge and future perspectives.
Døssing M
Int Arch Occup Environ Health; 1984; 53(3):205-18. PubMed ID: 6142865
[TBL] [Abstract][Full Text] [Related]
25. Divergent effects of different enzyme-inducing agents on endogenous and exogenous testosterone.
Bammel A; van der Mee K; Ohnhaus EE; Kirch W
Eur J Clin Pharmacol; 1992; 42(6):641-4. PubMed ID: 1623905
[TBL] [Abstract][Full Text] [Related]
26. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
Gachályi B; Tornyossy M; Vas A; Káldor A
Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880
[TBL] [Abstract][Full Text] [Related]
27. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
[TBL] [Abstract][Full Text] [Related]
28. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.
Roberts CJ; Jackson L; Halliwell M; Branch RA
Br J Clin Pharmacol; 1976 Oct; 3(5):907-13. PubMed ID: 973986
[TBL] [Abstract][Full Text] [Related]
29. Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.
Miguet JP; Mavier P; Soussy CJ; Dhumeaux D
Gastroenterology; 1977 May; 72(5 Pt 1):924-6. PubMed ID: 849823
[TBL] [Abstract][Full Text] [Related]
30. Drug induction of hepatic enzymes in the elderly.
Pearson MW; Roberts CJ
Age Ageing; 1984 Sep; 13(5):313-6. PubMed ID: 6496244
[TBL] [Abstract][Full Text] [Related]
31. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
van den Broek JM; Teunissen MW; Breimer DD
Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
[TBL] [Abstract][Full Text] [Related]
32. Induction of microsomal drug metabolism in man and in the rat by exposure to petroleum.
Harman AW; Frewin DB; Priestly BG
Br J Ind Med; 1981 Feb; 38(1):91-7. PubMed ID: 7470408
[TBL] [Abstract][Full Text] [Related]
33. Intravenous epoprostenol sodium does not increase hepatic microsomal enzyme activity in rats.
Carlton LD; Schmith VD; Brouwer KL
Prostaglandins; 1995; 50(5-6):341-7. PubMed ID: 8838243
[TBL] [Abstract][Full Text] [Related]
34. The effect of antipyrine and rifampin on the metabolism of diazepam.
Ohnhaus EE; Brockmeyer N; Dylewicz P; Habicht H
Clin Pharmacol Ther; 1987 Aug; 42(2):148-56. PubMed ID: 3608348
[TBL] [Abstract][Full Text] [Related]
35. Effects of microsomal enzyme induction on paracetamol metabolism in man.
Prescott LF; Critchley JA; Balali-Mood M; Pentland B
Br J Clin Pharmacol; 1981 Aug; 12(2):149-53. PubMed ID: 7306429
[TBL] [Abstract][Full Text] [Related]
36. Urinary D-glucaric acid excretion and plasma antipyrine kinetics during enzyme induction.
Davis M; Simmons CJ; Dordoni B; Williams R
Br J Clin Pharmacol; 1974 Jun; 1(3):253-7. PubMed ID: 22454957
[TBL] [Abstract][Full Text] [Related]
37. Research on the eventual enzymatic induction activity of cetiedil in rat and man.
Larousse C; Kergueris MF; Le Normand Y; Visset J
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):195-9. PubMed ID: 7390670
[TBL] [Abstract][Full Text] [Related]
38. Microsomal enzymes in patients with acute leukemia as determined by plasma half-life of antipyrine.
Higuchi T; Nakamura T; Uchino H
Cancer Chemother Pharmacol; 1980; 5(1):55-9. PubMed ID: 6936094
[TBL] [Abstract][Full Text] [Related]
39. On the antipyrine test in laboratory animals. Studies in the dog and monkey.
Vickers FF; Bowman TA; Dvorchik BH; Passananti GT; Hughes DM; Vesell ES
Drug Metab Dispos; 1989; 17(2):160-5. PubMed ID: 2565205
[TBL] [Abstract][Full Text] [Related]
40. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species.
McManus ME; Ilett KF
Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
